United Kingdom News Beep | NewsBeep.com
  • News Beep
  • United Kingdom
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
United Kingdom News Beep | NewsBeep.com
United Kingdom News Beep | NewsBeep.com
  • News Beep
  • United Kingdom
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

Inc.

127 posts
MMedication
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
Read More

FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval

  • August 7, 2026
NRx Pharmaceuticals, Inc. FDA identified no major deficiencies related to the ketamine drug product, ingredients, proposed labeling, CMC,…
MMental health
Court orders Meta to pay $567 million to address kids' mental health, safety on its platforms
Read More

Court orders Meta to pay $567 million to address kids’ mental health, safety on its platforms

  • August 7, 2026
A New Mexico court has ordered Instagram and Facebook parent company Meta to pay $567 million to address…
EEnvironment
DiCaprio and Bezos launch $200M fund for endangered species
Read More

DiCaprio and Bezos launch $200M fund for endangered species

  • August 4, 2026
LOS ANGELES (AP) — Foundations funded and co-founded by Leonardo DiCaprio and Jeff Bezos have launched an initiative…
MMedication
Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
Read More

Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic Cancer

  • July 24, 2026
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
EEconomy
New UK prime minister faces the same economic issues that sank his predecessor
Read More

New UK prime minister faces the same economic issues that sank his predecessor

  • July 22, 2026
LONDON (AP) — U.K. Prime Minister Andy Burnham’s announcements during his first 24 hours on the job underscore…
EEconomy
Hundreds of economists say 'we must act now' on AI’s economic impact
Read More

Hundreds of economists say ‘we must act now’ on AI’s economic impact

  • July 13, 2026
SAN FRANCISCO (AP) — Hundreds of economists say in an open letter that institutions “must act now” to…
EEconomy
Massive AI buildout poses latest inflation threat as consumers pay more for laptops and electricity
Read More

Massive AI buildout poses latest inflation threat as consumers pay more for laptops and electricity

  • July 13, 2026
WASHINGTON — American consumers — and the Federal Reserve — are being hit with another high-cost headache .…
MMedication
Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
Read More

European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process

  • July 8, 2026
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
MMedication
Nearly 1 million bottles of heart, kidney medications recalled nationwide over 'foreign substance'
Read More

Nearly 1 million bottles of heart, kidney medications recalled nationwide over ‘foreign substance’

  • July 3, 2026
Testing that raised concerns about possible foreign contamination has triggered a recall in the United States of nearly…
MMedication
Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
Read More

Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026

  • July 2, 2026
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
MMedication
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
Read More

Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control

  • June 30, 2026
Moleculin Biotech, Inc. Moleculin Biotech, Inc. INTERIM EFFICACY – N=45 INTENT TO TREAT (ITT) Both Annamycin dose arms…
MMedication
Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Read More

Unicycive Therapeutics Receives Complete Response Letter

  • June 30, 2026
— Complete Response Letter relates to deficiencies previously identified at third-party manufacturing vendor — — FDA inspection of…
United Kingdom News Beep | NewsBeep.com
www.newsbeep.com